Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation
- PMID: 12953019
- DOI: 10.1161/01.HYP.0000091371.53502.D3
Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation
Abstract
It has been reported that hypertension and obesity often coexist with hyperuricemia. To clarify the relations between serum uric acid, plasma norepinephrine, and insulin or leptin levels in subjects with weight gain-induced blood pressure elevation, we conducted the present longitudinal study. In 433 young, nonobese, normotensive men, body mass index, blood pressure, and levels of serum uric acid, fasting plasma norepinephrine, insulin, and leptin were measured every year for 5 years. Subjects were stratified by significant weight gain and/or blood pressure elevation (>10% in body mass index or mean blood pressure) for 5 years. At entry, blood pressure, uric acid, and norepinephrine values in subjects with blood pressure elevation were greater than in those without it, although body mass index, insulin, and leptin were similar. At entry, body mass index, blood pressure, uric acid, and norepinephrine in subjects with weight gain were greater than in those without weight gain. The increases in body mass index, mean blood pressure, uric acid, norepinephrine, insulin, and leptin for 5 years were greater in subjects with blood pressure elevation and/or weight gain than in subjects without, and those increases were greatest in subjects with weight gain whose blood pressure was elevated. By multiple regression analysis, basal mean blood pressure, norepinephrine, and uric acid were significant determinant factors of changes in mean blood pressure over 5 years, and basal body mass index, norepinephrine, and uric acid were significant determinant factors of changes in body mass index. These results demonstrate that serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation.
Similar articles
-
beta2- and beta3-Adrenoceptor polymorphisms relate to subsequent weight gain and blood pressure elevation in obese normotensive individuals.Hypertens Res. 2006 Dec;29(12):951-9. doi: 10.1291/hypres.29.951. Hypertens Res. 2006. PMID: 17378367
-
Beta2- and beta3-adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5 years.Circulation. 2005 Jun 28;111(25):3429-34. doi: 10.1161/CIRCULATIONAHA.104.519652. Epub 2005 Jun 13. Circulation. 2005. PMID: 15956122
-
Rebound weight gain as associated with high plasma norepinephrine levels that are mediated through polymorphisms in the beta2-adrenoceptor.Am J Hypertens. 2005 Nov;18(11):1508-16. doi: 10.1016/j.amjhyper.2005.05.006. Am J Hypertens. 2005. PMID: 16280290
-
Serum uric acid and leptin levels in metabolic syndrome: a quandary over the role of uric acid.Metabolism. 2007 Jun;56(6):751-6. doi: 10.1016/j.metabol.2007.01.006. Metabolism. 2007. PMID: 17512306
-
Weight gain-induced blood pressure elevation.Hypertension. 2000 May;35(5):1135-40. doi: 10.1161/01.hyp.35.5.1135. Hypertension. 2000. PMID: 10818077
Cited by
-
Association and interaction analysis of metabolic syndrome and serum uric acid on diastolic heart failure.J Endocrinol Invest. 2013 Sep;36(8):579-83. doi: 10.3275/8851. Epub 2013 Feb 12. J Endocrinol Invest. 2013. PMID: 23404264
-
Cross-sectional and longitudinal associations between serum uric acid and metabolic syndrome.Endocrine. 2012 Jun;41(3):450-7. doi: 10.1007/s12020-012-9629-8. Epub 2012 Feb 21. Endocrine. 2012. PMID: 22350659
-
Autonomic dysfunction in essential hypertension: A systematic review.Ann Med Surg (Lond). 2013 Dec 11;3(1):2-7. doi: 10.1016/j.amsu.2013.11.002. eCollection 2014 Mar. Ann Med Surg (Lond). 2013. PMID: 25568776 Free PMC article. Review.
-
The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality.BMC Nephrol. 2013 Jul 29;14:164. doi: 10.1186/1471-2369-14-164. BMC Nephrol. 2013. PMID: 23895142 Free PMC article. Review.
-
Urate transporter gene SLC22A12 polymorphisms associated with obesity and metabolic syndrome in Caucasians with hypertension.Kidney Blood Press Res. 2012;35(6):477-82. doi: 10.1159/000337370. Epub 2012 Jun 8. Kidney Blood Press Res. 2012. PMID: 22688828 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical